Paper Details 
Original Abstract of the Article :
Cardiac enzymes such as cytochrome P450 2J2 (CYP2J2) metabolize arachidonic acid (AA) to cardioprotective epoxyeicosatrienoic acids (EETs), which in turn are metabolized by soluble epoxide hydrolase (sEH) to dihydroxyeicosatrienoic acids (DHETs). As EETs and less potent DHETs exhibit cardioprotectiv...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/j.bcp.2017.09.012

データ提供:米国国立医学図書館(NLM)

Exploring the Impact of Dronedarone and Amiodarone on Cardiac Health

The intricate dance of enzymes in our bodies is essential for maintaining good health. This study focuses on the role of cytochrome P450 2J2 (CYP2J2), a cardiac enzyme that converts arachidonic acid (AA) into cardioprotective epoxyeicosatrienoic acids (EETs). These EETs, in turn, are transformed into dihydroxyeicosatrienoic acids (DHETs) by soluble epoxide hydrolase (sEH). This delicate balance is crucial for maintaining healthy heart function. The study investigated the effects of dronedarone and amiodarone, commonly used heart rhythm medications, and their active metabolites on these crucial enzymatic processes.

Unveiling the Influence on Cardiac EET Levels

This study revealed that dronedarone, amiodarone, and their active metabolites, N-desbutyldronedarone (NDBD) and N-desethylamiodarone (NDEA), exhibit varying levels of inhibition on the enzymes involved in EET production. Notably, dronedarone, amiodarone, and NDBD were found to decrease cardiac EET levels, while NDEA was predicted to elevate them. These findings suggest that the differential cardiac exacerbation potential of these medications could be attributed to their distinct inhibitory effects on CYP2J2 and sEH.

Navigating the Labyrinth of Cardiac Health

Understanding the intricate pathways that govern cardiac health is like navigating a labyrinth. This study unravels the effects of dronedarone and amiodarone on the enzymes responsible for EET production. These findings provide valuable insight into the potential mechanisms by which these medications impact cardiovascular health.

Dr. Camel's Conclusion

This study highlights the complex interplay between medications and the intricate workings of our bodies. By examining the influence of dronedarone and amiodarone on cardiac enzymes, the researchers unveil the delicate balance that governs heart health. Understanding these interactions is crucial for ensuring optimal patient outcomes and minimizing potential risks.

Date :
  1. Date Completed 2017-12-12
  2. Date Revised 2021-12-04
Further Info :

Pubmed ID

28958841

DOI: Digital Object Identifier

10.1016/j.bcp.2017.09.012

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.